4
We gratefully acknowledge financial support from the National
Research Foundation (NRF-2016M3A9E1918329, NRF-
32. Kamble, V. T.; Kadam, K. R.; Joshi, N. S.; Muley, D. B. Catal.
Commun. 2007, 8, 498.
3
3
3
3
3
3
3
3. Hazra, A.; Paira, P.; Sahu, K. B.; Banerjee, S.; Mondal, N. B.
Catal. Commun. 2008, 9, 1681.
4. Khan, K. M.; Taha, M.; Rahim, F.; Jamil, W.; Perveen, S.;
Choudhary, M. I. Journal of the Iran. Chem. Soc. 2012, 9, 81.
5. Xiang, J.; Wang, J.; Wang, M.; Meng, X.; Wu, A. Org. Biomol.
Chem. 2015, 13, 4240.
2
018R1D1A3B07044572, and 2020R1F1A1073052)
References and notes
1
2
.
.
Kochanowska-Karamyan, A. J.; Hamann, M. T. Chem. Rev. 2010,
10, 4489.
França, P. H.; Barbosa, D. P.; da Silva, D. L.; Ribeiro, Ê. A.;
Santana, A. E.; Santos, B. V.; Barbosa-Filho, J. M.; Quintans, J.
S.; Barreto, R. S.; Quintans-Júnior, L. J. BioMed. Res. Int. 2014,
6. Mohapatra, S. S.; Wilson, Z. E.; Roy, S.; Ley, S. V. Tetrahedron
1
2
017, 73, 1812.
7. Barbero, M.; Cadamuro, S.; Dughera, S.; Magistris, C.;
Venturello, P. Org. Biomol. Chem. 2011, 9, 8393.
8. Hartman, R. L.; Naber, J. R.; Zaborenko, N.; Buchwald, S. L.;
Jensen, K. F. Org.Process. Res. & Dev. 2010, 14, 1347.
9. Poe, S. L.; Cummings, M. A.; Haaf, M. P.; McQuade, D. T.
Angew. Chem. Int. Ed. 2006, 45, 1544.
2
014, 375.
3
4
.
.
Michnovicz, J. J.; Bradlow, H. L. NUTR CANCER 1991, 16, 59.
Ge, X.; Yannai, S.; Rennert, G.; Gruener, N.; Fares, F. A.
Biochem. Biophys. Res. Commun 1996, 228, 153.
Zeligs, M. A. J. Med. Food. 1998, 1, 67.
Karthik, M.; Tripathi, A.; Gupta, N.; Palanichamy, M.;
Murugesan, V. Catal. Commun. 2004, 5, 371.
Kim, Y. S.; Milner, J. J. Nutr. Biochem. 2005, 16, 65.
Rogan, E. G. in vivo 2006, 20, 221.
4
4
4
0. Ma, J.; Lee, S. M.-Y.; Yi, C.; Li, C.-W. Lab Chip. 2017, 17, 209.
1. Shang, L.; Cheng, Y.; Zhao, Y. Chem. Rev. 2017, 117, 7964.
2. Tenje, M.; Fornell, A.; Ohlin, M.; Nilsson, J. Anal. Chem. 2017,
5
6
.
.
9
0, 1434.
7
8
9
1
1
.
.
.
Harvey, A. L. Drug. Discov. Today. 2008, 13, 894.
0. Kasar, S. B.; Thopate, S. R. Curr.Org. Synth. 2018, 15, 110.
1. He, X.; Hu, S.; Liu, K.; Guo, Y.; Xu, J.; Shao, S. Org. Lett. 2006,
Supplementary Material
8
, 333.
Additional supplementary information is available in the online
version of this article.
1
1
1
2. Batista, R. M.; Costa, S. P.; Silva, R. M.; Lima, N. E.; Raposo, M.
M. M. Dyes. Pigm. 2014, 102, 293.
3. Ghorbani-Vaghei, R.; Veisi, H.; Keypour, H.; Dehghani-
Firouzabadi, A. A. Mol. Divers. 2010, 14, 87.
4. Sharma, G.; Reddy, J. J.; Lakshmi, P. S.; Krishna, P. R.
Tetrahedron Lett. 2004, 45, 7729.
5. Deb, M. L.; Bhuyan, P. J. Tetrahedron Lett. 2006, 47, 1441.
6. Heravi, M. M.; Bakhtiari, K.; Fatehi, A.; Bamoharram, F. F.
Catal. Commun. 2008, 9, 289.
Declaration of interests
1
1
☒
The authors declare that they have no known
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
7. Tayebee, R.; Nehzat, F.; Rezaei-Seresht, E.; Mohammadi, F. Z.;
Rafiee, E. Catal. A: Chem. 2011, 351, 154.
8. Sheng, S.-R.; Wang, Q.-Y.; Ding, Y.; Liu, X.-L.; Cai, M.-Z.
Catal. Lett. 2009, 128, 418.
competing financial interests or personal
relationships that could have appeared to influence
the work reported in this paper.
9. M Vahdat, S.; Khaksar, S.; Baghery, S. L Lett. Org. Chem.2012, 9,
1
38.
0. Mulla, S. A.; Sudalai, A.; Pathan, M. Y.; Siddique, S. A.; Inamdar,
S. M.; Chavan, S. S.; Reddy, R. S. RSC Adv. 2012, 2, 3525.
1. Mohapatra, S. S.; Mukhi, P.; Mohanty, A.; Pal, S.; Sahoo, A. O.;
Das, D.; Roy, S. Tetrahedron Lett. 2015, 56, 5709.
☐The authors declare the following financial
interests/personal relationships which may be
considered as potential competing interests:
2. Baig, N.; Shelke, G. M.; Kumar, A.; Sah, A. K. Catal. Lett. 2016,
1
46, 333.
3. Moon, S.-Y.; Jung, S.-H.; Kim, U. B.; Kim, W.-S. RSC Adv. 2015,
, 79385.
5
4. Adeyemi, A.; Bergman, J.; Brånalt, J.; Sävmarker, J.; Larhed, M.
Org. Process Res. Dev. 2017, 21, 947.
5. Alam, K.; Kim, J. G.; Kang, D. Y.; Park, J. K. Adv. Synth. Catal.
2
019, 361, 1683.
6. Borra, S.; Borkotoky, L.; Newar, U. D.; Kalwar, A.; Das, B.;
Maurya, R. A. Org. Biomol. Chem. 2019, 17, 5971.
7. Zhan, W.; Ji, L.; Ge, Z.-m.; Wang, X.; Li, R.-t. Tetrahedron 2018,
7
4, 1527.
8. Shvydkiv, O.; Jähnisch, K.; Steinfeldt, N.; Yavorskyy, A.;
Oelgemöller, M. Catal. Today. 2018, 308, 102.
9. Laudadio, G.; Bartolomeu, A. d. A.; Verwijlen, L. M.; Cao, Y.; de
Oliveira, K. T.; Noël, T. J. Am. Chem. Soc. 2019, 141, 11832.
0. Fanelli, F.; Parisi, G.; Degennaro, L.; Luisi, R. Beilstein
J. Org. Chem 2017, 13, 520.
The bioactive substances, Bis(indolyl)methanes and
Tris(indolyl)methanes, were prepared using single-
phase and droplet-based continuous flow methods.
The droplet-based continuous flow synthesis
offered excellent process stability and yields.
1. Giovine, A.; Musio, B.; Degennaro, L.; Falcicchio, A.; Nagaki,
A.; Yoshida, J.-i.; Luisi, R. Chem. Eur. J. 2013, 19, 1872.